secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001213900-25-052141
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar boosts authorized shares to 390M, completes 1-for-15 reverse split effective June 8
--------------------------------------------------------------------------------

- Authorized common shares increased from 300M to 390M, effective June 6, 2025, stockholder-approved May 23, 2025.
- Reverse stock split at 1-for-15 ratio effective 11:59 p.m. ET June 8; split-adjusted trading starts June 9 under NKTR.
- Fractional shares rounded up at DTC for directly held shares; rounded down to nearest whole share for equity awards.
- Total authorized shares remain at 390M after reverse split due to prior increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390025052141/0001213900-25-052141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390025052141/ea0244929-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-052141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer